Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Pallone

Showing results (61-70 of 163) with videos related to

Pageof 17
Sort By:
Gastroenterology|March 1, 1994
Vasoactive intestinal polypeptide modulates the in vitro immunoglobulin A production by intestinal lamina propria lymphocytesM Boirivant, S Fais, B Annibale, et al.
Journal of Interferon Research|October 1, 1994
Interferon expression in Crohn's disease patients: increased interferon-gamma and -alpha mRNA in the intestinal lamina propria mononuclear cellsS Fais, M R Capobianchi, M Silvestri, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 27, 2009
Large villous adenoma of the appendix: a case treated with sequential endoscopic-minimal surgical techniqueI Stroppa, R Lionetti, F Andrei, et al.
Journal of Neuroimmunology|March 1, 1991
Effects of somatostatin on human intestinal lamina propria lymphocytes. Modulation of lymphocyte activationS Fais, B Annibale, M Boirivant, et al.
The Italian Journal of Gastroenterology|January 1, 1993
Serum angiotensin converting enzyme activity in Crohn's disease and ulcerative colitisC Letizia, C D'Ambrosio, D Agostini, et al.
Gastroenterology|April 1, 1997
Interleukin 12 is expressed and actively released by Crohn's disease intestinal lamina propria mononuclear cellsG Monteleone, L Biancone, R Marasco, et al.
Gut|November 20, 2009
Long-term safety of Infliximab for the treatment of inflammatory bowel disease: does blocking TNFalpha reduce colitis-associated colorectal carcinogenesis?L Biancone, C Petruzziello, E Calabrese, et al.
The Italian Journal of Gastroenterology|November 1, 1992
Antibacterial drugs in Crohn's diseaseF Pallone, M Boirivant, S Fais, et al.
FEMS Immunology and Medical Microbiology|February 1, 1995
Isotypic analysis of specific antibody response in serum, saliva, gastric and rectal homogenates of Helicobacter pylori-infected patientsF Luzza, M Imeneo, M Maletta, et al.
Journal of Clinical Gastroenterology|February 1, 1988
Clinical and laboratory indicators of extent of ulcerative colitis. Serum C-reactive protein helps the mostC Prantera, M Davoli, R Lorenzetti, et al.
Pageof 17

Showing results (61-70 of 163) with videos related to

Sort By:
Pageof 17
Gastroenterology|March 1, 1994
Vasoactive intestinal polypeptide modulates the in vitro immunoglobulin A production by intestinal lamina propria lymphocytesM Boirivant, S Fais, B Annibale, et al.
Journal of Interferon Research|October 1, 1994
Interferon expression in Crohn's disease patients: increased interferon-gamma and -alpha mRNA in the intestinal lamina propria mononuclear cellsS Fais, M R Capobianchi, M Silvestri, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 27, 2009
Large villous adenoma of the appendix: a case treated with sequential endoscopic-minimal surgical techniqueI Stroppa, R Lionetti, F Andrei, et al.
Journal of Neuroimmunology|March 1, 1991
Effects of somatostatin on human intestinal lamina propria lymphocytes. Modulation of lymphocyte activationS Fais, B Annibale, M Boirivant, et al.
The Italian Journal of Gastroenterology|January 1, 1993
Serum angiotensin converting enzyme activity in Crohn's disease and ulcerative colitisC Letizia, C D'Ambrosio, D Agostini, et al.
Gastroenterology|April 1, 1997
Interleukin 12 is expressed and actively released by Crohn's disease intestinal lamina propria mononuclear cellsG Monteleone, L Biancone, R Marasco, et al.
Gut|November 20, 2009
Long-term safety of Infliximab for the treatment of inflammatory bowel disease: does blocking TNFalpha reduce colitis-associated colorectal carcinogenesis?L Biancone, C Petruzziello, E Calabrese, et al.
The Italian Journal of Gastroenterology|November 1, 1992
Antibacterial drugs in Crohn's diseaseF Pallone, M Boirivant, S Fais, et al.
FEMS Immunology and Medical Microbiology|February 1, 1995
Isotypic analysis of specific antibody response in serum, saliva, gastric and rectal homogenates of Helicobacter pylori-infected patientsF Luzza, M Imeneo, M Maletta, et al.
Journal of Clinical Gastroenterology|February 1, 1988
Clinical and laboratory indicators of extent of ulcerative colitis. Serum C-reactive protein helps the mostC Prantera, M Davoli, R Lorenzetti, et al.
Pageof 17